Skip to search formSkip to main contentSkip to account menu

Iron Chelator [EPC]

Known as: Iron Chelator 
National Institutes of Health

Related topics

Related topics

1 relation
Iron Chelating Activity [MoA]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Fe 2 + chelator proferrorosamine A : a gene cluster of Erwinia rhapontici P 45 involved in its synthesis and its impact on growth of Erwinia amylovora CFBP 1430
Correspondence Cosima Pelludat cosima.pelludat@ agroscope.admin.ch Institute of Food and Beverage Innovation, Zurich University… 
2013
2013
Efficacy of deferasirox for the treatment of iron overload in a child affected by Juvenile Hemochromatosis
We report the case of a 7 years old girl with Juvenile Hemochromatosis, due to homozygous mutation of HJV, which had increased… 
2008
2008
Effect of probucol and desferroxamine against adriamycin toxicity in cardiac and renal tissues of rats
Adriamycin (ADR) is an anthracycline glycoside with a broad spectrum of therapeutic activity against various tumors; however, its… 
Review
2006
Review
2006
Exjade (ICL 670): A new oral iron chelator.
ICL670(deferasirox) is a tridentate oral iron chelator that has shown high efficacy and theraputic safety in preclinical and… 
Review
2006
Review
2006
Deferasirox (Exjade): a new iron chelator.
2004
2004
Chelator-Octreotate Using a Cross-Bridged Macrocyclic 3 Tyr Labeled − Preparation and Biological Evaluation of Copper-64
Purpose: Somatostatin receptors (SSTr) are expressed on many neuroendocrine tumors, and several radiotracers have been developed… 
1992
1992
Deferoxamine, an iron chelator, reduces myocardial injury and free radical generation in isolated neonatal rabbit hearts subjected to global ischemia-reperfusion
1985
1985
Red cell ghost-entrapped deferoxamine as a model clinical targeted delivery system for iron chelators and other compounds.
In iron overload resulting from repeated blood transfusion, phagocytic reticuloendothelial cells are the primary and major sites… 
1983
1983
Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
An iron chelator of low water solubility, HBED, has been encapsulated in the lipid bilayers of unilamellar and multilamellar… 
1980
1980
Evaluation of iron-chelating agents in cultured heart muscle cells. Identification of a potential drug for chelation therapy.
Primary cultures of neonatal rat cardiac muscle cells incorporated radioiron from both [55Fe]transferrin and 59FeCl3 (added…